Lina Silva Salinas, Author at SIOG

Use of a Comprehensive Geriatric Assessment for the Management of Elderly Patients With Advanced Non-Small-Cell Lung Cancer: The Phase III Randomized ESOGIA-GFPC-GECP 08-02 Study.

Lina Silva Salinas2021-07-29T22:38:02+02:00

Corre R, Greillier L, Le Caër H, Audigier-Valette C, Baize N, Bérard H, Falchero L, Monnet I, Dansin E, Vergnenègre A, Marcq M, Decroisette C, Auliac JB, Bota S, Lamy R, Massuti B, Dujon C, Pérol M, Daurès JP, Descourt R, Léna H, Plassot C, Chouaïd C.J Clin Oncol. 2016 Feb 16. pii: JCO635839. [Epub ahead of print]

Use of a Comprehensive Geriatric Assessment for the Management of Elderly Patients With Advanced Non-Small-Cell Lung Cancer: The Phase III Randomized ESOGIA-GFPC-GECP 08-02 Study.Lina Silva Salinas2021-07-29T22:38:02+02:00

Treating recurrent postmenopausal vasomotor symptoms in a patient with a positive family history for breast cancer.

Lina Silva Salinas2021-07-29T22:38:02+02:00

Leong C, Lake J. Consult Pharm. 2015 Jan;30(1):38-44. doi: 10.4140/TCP.n.2015.38.

Treating recurrent postmenopausal vasomotor symptoms in a patient with a positive family history for breast cancer.Lina Silva Salinas2021-07-29T22:38:02+02:00

Why the oncologist should consider the nutritional status of the elderly cancer patient.

Lina Silva Salinas2021-07-29T22:38:02+02:00

Bozzetti F Nutrition. 2015 Apr;31(4):590-3. doi: 10.1016/j.nut.2014.12.005. Epub 2014 Dec 12.

Why the oncologist should consider the nutritional status of the elderly cancer patient.Lina Silva Salinas2021-07-29T22:38:02+02:00

Treatment of Hodgkin lymphoma in older patients

Lina Silva Salinas2021-07-29T22:38:02+02:00

Radford J. Blood. 2015 Dec 24;126(26):2768-9. doi: 10.1182/blood-2015-10-671388.

Treatment of Hodgkin lymphoma in older patientsLina Silva Salinas2021-07-29T22:38:02+02:00

Chemoradiation may increase survival for a subset of elderly head and neck cancer patients

Lina Silva Salinas2021-07-29T22:38:02+02:00

Garth Sundem - Colorado Cancer Blog (University of Colorado Cancer Center) Feb. 18, 2016

Chemoradiation may increase survival for a subset of elderly head and neck cancer patientsLina Silva Salinas2021-07-29T22:38:02+02:00

Elderly risk more complications after major cancer surgery

Lina Silva Salinas2021-07-29T22:38:02+02:00

Lisa Rapaport interviewed several doctors including Dr Siri Rostoft and Dr Kwok-Leung Cheung both SIOG members - Reuters Health

Elderly risk more complications after major cancer surgeryLina Silva Salinas2021-07-29T22:38:02+02:00

How I treat fragile myeloma patients

Lina Silva Salinas2021-07-29T22:38:03+02:00

Larocca A, Palumbo A. Blood. 2015 Nov 5;126(19):2179-85. doi: 10.1182/blood-2015-05-612960. Epub 2015 Aug 31.

How I treat fragile myeloma patientsLina Silva Salinas2021-07-29T22:38:03+02:00

The Prognostic Importance of Frailty in Cancer Survivors

Lina Silva Salinas2021-07-29T22:38:03+02:00

Brown JC, Harhay MO, Harhay MN. J Am Geriatr Soc. 2015 Dec;63(12):2538-2543. doi: 10.1111/jgs.13819. Epub 2015 Nov 14.

The Prognostic Importance of Frailty in Cancer SurvivorsLina Silva Salinas2021-07-29T22:38:03+02:00

Taxanes in the treatment of breast cancer: Have we better defined their role in older patients? A position paper from a SIOG Task Force

Lina Silva Salinas2021-07-29T22:38:03+02:00

L. Biganzoli, M. Aapro, Sibylle Loibl, Hans Wildiers, Etienne Brain. Cancer Treatment Reviews February 2016 Volume 43, Pages 19–26

Taxanes in the treatment of breast cancer: Have we better defined their role in older patients? A position paper from a SIOG Task ForceLina Silva Salinas2021-07-29T22:38:03+02:00

Efficacy and safety of enzalutamide in patients 75 years or older with chemotherapy-naive metastatic castration-resistant prostate cancer: results from PREVAIL.

Lina Silva Salinas2021-07-29T22:38:03+02:00

Graff JN, Baciarello G, Armstrong AJ, Higano CS, Iversen P, Flaig TW, Forer D, Parli T, Phung D, Tombal B, Beer TM, Sternberg CN. Ann Oncol. 2016 Feb;27(2):286-94. doi: 10.1093/annonc/mdv542. Epub 2015 Nov 16.

Efficacy and safety of enzalutamide in patients 75 years or older with chemotherapy-naive metastatic castration-resistant prostate cancer: results from PREVAIL.Lina Silva Salinas2021-07-29T22:38:03+02:00

Lina_S

About Lina Silva Salinas

SIOG Head Office

ECOSOC Special

Quick links

Stay in the loop with SIOG’s newsletter!

Lina_S

About Lina Silva Salinas

Stay in touch and share our news!

SIOG Head Office

ECOSOC Special

Quick links

Stay in the loop with SIOG’s newsletter!